Literature DB >> 8916378

Absence of significant hemodynamic changes in the fetus following maternal betamethasone administration.

B J Cohlen1, R H Stigter, J B Derks, E J Mulder, G H Visser.   

Abstract

Maternal betamethasone administration causes a transient but considerable reduction in fetal body and breathing movements and in fetal heart rate variation. The aim of the present prospective study was to investigate whether there is evidence of circulatory changes in fetal, placental or uterine arteries, consistent with hypoxemia. Eighteen women at risk for preterm delivery received betamethasone to enhance fetal lung maturation. Doppler studies were performed before treatment, and 24 and 72 h after the second dose of betamethasone. Blood flow velocity waveforms were obtained from both uterine arteries, umbilical arteries, fetal descending aorta, fetal renal artery, and fetal cerebral arteries. No significant changes occurred in the pulsatility index of any of these blood vessels, suggesting that the transient reduction in fetal heart rate variation and fetal body and breathing movements following maternal betamethasone administration is not mediated through fetal hypoxemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916378     DOI: 10.1046/j.1469-0705.1996.08040252.x

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  7 in total

1.  Betamethasone effects on fetal sheep cerebral blood flow are not dependent on maturation of cerebrovascular system and pituitary-adrenal axis.

Authors:  Matthias Löhle; Thomas Müller; Carola Wicher; Marcus Roedel; Harald Schubert; Otto W Witte; Peter W Nathanielsz; Matthias Schwab
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

2.  Effects of betamethasone administration to the fetal sheep in late gestation on fetal cerebral blood flow.

Authors:  M Schwab; M Roedel; M A Anwar; T Müller; H Schubert; L F Buchwalder; B Walter; W Nathalielsz
Journal:  J Physiol       Date:  2000-11-01       Impact factor: 5.182

3.  Effect of maternal betamethasone administration on feto-placental vascular resistance in the mouse†.

Authors:  Lindsay S Cahill; Clare L Whitehead; Sebastian R Hobson; Greg Stortz; John C Kingdom; Ahmet Baschat; Kellie E Murphy; Lena Serghides; Christopher K Macgowan; John G Sled
Journal:  Biol Reprod       Date:  2019-10-25       Impact factor: 4.285

4.  Sex differences in modulation of fetoplacental vascular resistance in growth-restricted mouse fetuses following betamethasone administration: comparisons with human fetuses.

Authors:  Lindsay S Cahill; Shiri Shinar; Clare L Whitehead; Sebastian R Hobson; Greg Stortz; Viji Ayyathurai; Anjana Ravi Chandran; Anum Rahman; John C Kingdom; Ahmet Baschat; Kellie E Murphy; Lena Serghides; Christopher K Macgowan; John G Sled
Journal:  Am J Obstet Gynecol MFM       Date:  2020-10-06

5.  Comparing the effects of antenatal betamethasone on Doppler velocimetry between intrauterine growth restriction with and without preeclampsia.

Authors:  Kobra Shojaei; Nooshin Mohammadi
Journal:  Glob J Health Sci       Date:  2015-01-13

6.  The short term fetal cardiovascular effects of corticosteroids used in obstetrics.

Authors:  Amanda Henry; Antonia Shand; Alec Welsh
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

7.  Antenatal dexamethasone effect on Doppler blood flow velocity in women at risk for preterm birth: prospective case series.

Authors:  Elsnosy Elwany; Shaaban Omar; Abbas Ahmed; Gaber Heba; Darwish Atef
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.